Targeting farnesoid X receptor for liver and metabolic disorders
- 1 July 2007
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 13 (7) , 298-309
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXRMolecular Cell, 2003
- Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing LanosterolMolecular and Cellular Biology, 2003
- Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional ActivationJournal of Biological Chemistry, 2003
- 6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic ActivityJournal of Medicinal Chemistry, 2002
- Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promotersGene, 2002
- Identification of a Chemical Tool for the Orphan Nuclear Receptor FXRJournal of Medicinal Chemistry, 2000
- Identification of a Nuclear Receptor for Bile AcidsScience, 1999
- Bile Acids: Natural Ligands for an Orphan Nuclear ReceptorScience, 1999
- Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BARMolecular Cell, 1999
- Identification of a nuclear receptor that is activated by farnesol metabolitesCell, 1995